International Neuroblastoma Pathology Classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group

Cancer

Volumn 92, Issue 9, 2001, Pages 2451-2461

  Shimada, Hiroyuki ^a,b   Umehara, Shunsuke ^a   Monobe, Yasumasa ^a   Hachitanda, Yoichi ^a   Nakagawa, Atsuko ^a   Goto, Shoko ^a   Gerbing, Robert B ^b   Stram, Daniel O ^c   Lukens, John N ^d   Matthay, Katherine K ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age; Differentiation; Histopathology; International Neuroblastoma Pathology Classification; Mitosis karyorrhexis index; Neuroblastic tumors; Prognosis; Shimada system

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CELL DIFFERENTIATION; CHILD; CHILDHOOD CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; AGE FACTORS; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; GANGLIONEUROBLASTOMA; HUMANS; INFANT; INTERNATIONAL COOPERATION; MALE; MITOSIS; NEUROBLASTOMA; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0035498612     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S     Document Type: Article

References (20)

1. Childhood cancer
2. The International Neuroblastoma Pathology Classification (the Shimada system)
3. Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee
4. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas
5. Successful treatment of Stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group study
6. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
7. Favorable biology and outcome of Stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study
8. Biologic variables in the outcome of Stages I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study
9. Biologic factors determine prognosis in Stage IV neuroblastoma < 1year of age: A prospective Children's Cancer Group Study
10. A proposed staging for children with neuroblastoma
11. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
12. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: The Childrens Cancer Study Group experience
13. Nonparametric estimation from incomplete observations
14. On a test of whether one of two random variables is stochastically larger than the other
15. Excellent outcome of Stage II neuroblastoma is independent of residual disease and radiation therapy
16. Mediastinal tumors in children: Experience with 196 cases
17. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma
18. Splicing pattern of the high affinity nerve growth factor receptor (trkA) transcript in neuroblastomas: Correlation with histopathology and clinical outcome
19. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular
20. Prognostic value of histopathology in advanced neuroblastoma: A report from the Childrens Cancer Study Group